A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States (Q38052141)
Jump to navigation
Jump to search
scientific article published on 15 October 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States |
scientific article published on 15 October 2012 |
Statements
1 reference
A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States (English)
1 reference
Adonis Stassinopoulos
1 reference
Steven Kleinman
1 reference
William Reed
1 reference
15 October 2012
1 reference
1 reference
53
1 reference
7
1 reference
1603-1618
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference